Clinical prediction tool for extended-spectrum beta-lactamase-producing enterobacterales as the etiology of a bloodstream infection in solid organ transplant recipients
- PMID: 33724633
- PMCID: PMC8443704
- DOI: 10.1111/tid.13599
Clinical prediction tool for extended-spectrum beta-lactamase-producing enterobacterales as the etiology of a bloodstream infection in solid organ transplant recipients
Abstract
Background: Multidrug-resistant Gram-negative bacterial infections are increasingly common among solid organ transplant (SOT) recipients, leading to challenges in the selection of empiric antimicrobial therapy. We sought to develop a clinical tool to predict which SOT recipients are at high risk for extended-spectrum beta-lactamase (ESBL)-producing Enterobacterales (EB) bloodstream infection (BSI).
Methods: A multicenter case-control study was performed. The source population included SOT recipients with an EB BSI between 2005 and 2018. Cases were those with ESBL-EB BSI; controls were those with non-ESBL EB BSI. The population was subdivided into derivation and validation cohorts based on study site. The predictive tool was developed in the derivation cohort through iterative multivariable logistic regression analyses that maximized the area under the receiver-operating curve (AUC). External validity was assessed using the validation cohort.
Results: A total of 897 SOT recipients with an EB BSI were included, of which 539 were assigned to the derivation cohort (135, 25% ESBL-EB) and 358 to the validation cohort (221, 62% ESBL-EB). Using multivariable analyses, the most parsimonious model that was predictive of ESBL-EB BSI consisted of 10 variables, which fell into four clinical categories: prior colonization or infection with EB organisms, recent antimicrobial exposures, severity of preceding illness, and immunosuppressive regimen. This model achieved an AUC of 0.81 in the derivation cohort and 0.68 in the validation cohort.
Conclusions: Though further refinements are needed in additional populations, this tool shows promise for guiding empiric therapy for SOT recipients with EB BSI.
Keywords: bloodstream infection; enterobacterales; extended-spectrum beta-lactamase; predictive tool; transplant.
© 2021 Wiley Periodicals LLC.
Conflict of interest statement
CONFLICT OF INTEREST
Emily Blumberg receives research support from Takeda, Merck, and Hologic; is a member of a Data and Safety Monitoring Board (DSMB) for Amplyx; and serves as a member of the scientific advisory committee for Merck. Jennifer Han was affiliated with the University of Pennsylvania during the conduct of this research and is now employed by and holds shares in the GlaxoSmithKline group of companies. Ebbing Lautenbach is a member of a DSMB for Merck and serves as a member of the scientific advisory committees for Paratek and Shionogi. Kevin Alby serves on the scientific advisory boards for Becton Dickinson and Shionogi. Warren Bilker is a member of multiple DSMBs for Genentech. None of these conflicts are relevant to this article. All other authors report no conflicts of interest relevant to this article.
Figures
Similar articles
-
Extended-spectrum β-lactamase-producing and carbapenem-resistant Enterobacterales bloodstream infection after solid organ transplantation: Recent trends in epidemiology and therapeutic approaches.Transpl Infect Dis. 2022 Aug;24(4):e13881. doi: 10.1111/tid.13881. Epub 2022 Jun 28. Transpl Infect Dis. 2022. PMID: 35691028 Free PMC article. Review.
-
Risk Factors for Extended-Spectrum β-lactamase-Producing Enterobacterales Bloodstream Infection Among Solid-Organ Transplant Recipients.Clin Infect Dis. 2021 Mar 15;72(6):953-960. doi: 10.1093/cid/ciaa190. Clin Infect Dis. 2021. PMID: 32149327 Free PMC article.
-
Temporal trends, risk factors and outcomes of infections due to extended-spectrum β-lactamase producing Enterobacterales in Swiss solid organ transplant recipients between 2012 and 2018.Antimicrob Resist Infect Control. 2021 Mar 7;10(1):50. doi: 10.1186/s13756-021-00918-7. Antimicrob Resist Infect Control. 2021. PMID: 33678189 Free PMC article.
-
Clinical Risk Score for Prediction of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Bloodstream Isolates.Infect Control Hosp Epidemiol. 2017 Mar;38(3):266-272. doi: 10.1017/ice.2016.292. Epub 2016 Dec 19. Infect Control Hosp Epidemiol. 2017. PMID: 27989244
-
Extended-spectrum beta-lactamase-producing bacterial infections in adult solid organ transplant recipients.Ann Pharmacother. 2011 Mar;45(3):309-16. doi: 10.1345/aph.1P661. Epub 2011 Mar 8. Ann Pharmacother. 2011. PMID: 21386016 Review.
Cited by
-
Extended-spectrum β-lactamase-producing and carbapenem-resistant Enterobacterales bloodstream infection after solid organ transplantation: Recent trends in epidemiology and therapeutic approaches.Transpl Infect Dis. 2022 Aug;24(4):e13881. doi: 10.1111/tid.13881. Epub 2022 Jun 28. Transpl Infect Dis. 2022. PMID: 35691028 Free PMC article. Review.
-
A simple nomogram for predicting infectious diseases in adult kidney transplantation recipients.Front Public Health. 2022 Aug 31;10:944137. doi: 10.3389/fpubh.2022.944137. eCollection 2022. Front Public Health. 2022. PMID: 36117592 Free PMC article.
-
The threat of multidrug-resistant/extensively drug-resistant Gram-negative respiratory infections: another pandemic.Eur Respir Rev. 2022 Oct 19;31(166):220068. doi: 10.1183/16000617.0068-2022. Print 2022 Dec 31. Eur Respir Rev. 2022. PMID: 36261159 Free PMC article.
-
Challenges of Antimicrobial Resistance and Stewardship in Solid Organ Transplant Patients.Curr Infect Dis Rep. 2022;24(5):63-75. doi: 10.1007/s11908-022-00778-1. Epub 2022 Apr 30. Curr Infect Dis Rep. 2022. PMID: 35535263 Free PMC article. Review.
References
-
- Aguiar EB, Maciel LC, Halpern M, et al.Outcome of bacteremia caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae after solid organ transplantation. Transplant Proc. 2014;46(6):1753–1756. - PubMed
-
- Winters HA, Parbhoo RK, Schafer JJ, Goff DA. Extended-spectrum beta-lactamase-producing bacterial infections in adult solid organ transplant recipients. Ann Pharmacother. 2011;45(3):309–316. - PubMed
-
- Shi SH, Kong HS, Xu J, et al.Multidrug resistant gram-negative bacilli as predominant bacteremic pathogens in liver transplant recipients. Transpl Infect Dis. 2009;11(5):405–412. - PubMed
-
- Linares L, García-Goez JF, Cervera C, et al.Early bacteremia after solid organ transplantation. Transplant Proc. 2009;41(6):2262–2264. - PubMed
-
- Singh N, Wagener MM, Obman A, Cacciarelli TV, de Vera ME, Gayowski T. Bacteremias in liver transplant recipients: shift toward gram-negative bacteria as predominant pathogens. Liver Transpl. 2004;10(7):844–849. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- K01-AI137317/NH/NIH HHS/United States
- K24 AI080942/AI/NIAID NIH HHS/United States
- FOA#CK16-004/CC/CDC HHS/United States
- K24-AI080942/NH/NIH HHS/United States
- UM1 AI104681/AI/NIAID NIH HHS/United States
- U54 CK000485/CK/NCEZID CDC HHS/United States
- U54 CK000163/CK/NCEZID CDC HHS/United States
- 5 UM 1AI104681-05/National Institute of Allergy and Infectious Diseases
- K01 AI137317/AI/NIAID NIH HHS/United States
- FOA#CK16-004/CC/CDC HHS/United States
- K01-AI137317/NH/NIH HHS/United States
- K24-AI080942/NH/NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical